Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. 002038

Market Closed
30 Sep, 06:57
XSHE XSHE
¥
7. 92
+0.71
+9.85%
¥
8.14B Market Cap
- P/E Ratio
0.6% Div Yield
43,684,652 Volume
- Eps
¥ 7.21
Previous Close
Day Range
7.45 7.93
Year Range
6.16 16.09

002038 Chart

Beijing SL Pharmaceutical Co., Ltd. Profile

Drug Manufacturers—Specialty & Generic Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE000001L31 ISIN
China Country
856 Employees
- Last Dividend
4 Jul 2019 Last Split
- IPO Date

Overview

Beijing SL Pharmaceutical Co., Ltd., established in 1994 under its former name Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd., and underwent a name change in 1998 to its current designation. Operating from the heart of Beijing, in the People’s Republic of China, this biopharmaceutical entity engages profoundly in the realms of research, development, production, and international marketing of genetic engineering drugs and its related products. Serving not only the domestic market of China but also catering to international demands, the company has established itself as a significant player in the biopharmaceutical sector.

Products and Services

Beijing SL Pharmaceutical Co., Ltd. offers a comprehensive range of formulations and active pharmaceutical ingredients (APIs), catering to various therapeutic areas:

  • Temozolomide, Arsenic Trioxide, Lenalidomide Capsules, and More: Focused on oncology, these drugs are essential for treating various cancers.
  • Docetaxel, Paclitaxel: Used in chemotherapy treatments to inhibit cancer cell growth.
  • Recombinant Proteins (Human Granulocyte Colony-Stimulating Factor, Human Interleukin-11, Human Interleukin-2): These are crucial in enhancing the immune system's functionality, especially in cancer treatment.
  • Thymopentin, Vinorelbine Bitartrate: These agents are used for their immune-modulating and anti-cancer properties.
  • Recombinant Human Basic Fibroblast Growth Factor, Liraglutide: With applications in regenerative medicine and diabetes management, respectively, showcasing the company's involvement in endocrinology and systemic treatments.
  • Insulin Aspart Family: Contributes to diabetes care by providing fast-acting insulin variants.
  • Recombinant Human Follitropin(rh-fsh), Ciclosporin: Address reproductive health and immunosuppression, aiding fertility treatments and organ transplant procedures respectively.
  • Antivirals and Antibiotics (Adefovir Dipivoxil, Levofloxacin Hydrochloride, Azithromycin): Offering solutions in infectious diseases.
  • Anticoagulants and Cardiovascular Drugs (Rivaroxaban, Enoxaparin Sodium, Simvastatin, Telmisartan): Catering to cardiovascular health and thrombotic conditions.
  • Ginkgo Biloba Extract, Coenzyme Complex: These supplements support cognitive functions and general wellness.
  • Other Specialties (Omeprazole, Ademetionine 1,4-Butanedisulfonate, Glutathione): Encompasses gastrointestinal treatments, liver health supplements, and antioxidant therapies.

Apart from finished formulations, Beijing SL Pharmaceutical Co., Ltd. also specializes in the production of high-quality active pharmaceutical ingredients (APIs), thereby contributing vitally to the pharmaceutical industry's supply chain both domestically and internationally.

Contact Information

Address: Building 1, Bitongyuan
Phone: 86 10 6872 7127